Publications

Innovation policy instruments (‎non-price)‎ for medical innovation

Report report for World Health Organization Europe Office / Oslo Medicines Initiative (contributing author)

September 2022

This Oslo Medicines Initiative technical report presents a broad range of instruments available to national policy-makers in support of innovation for new medicines (‎excluding those focused on price)‎ explores various types of policy instrument, based on reviews of the literature on policies for innovation in the medical and other sectors.

Screenshot cover WHO report.png

Valuing Vaccines: Ensuring Australia's access to vaccines today and tomorrow

Report commissioned by Sanofi

February 2022

Report prepared on trends in global health, health policy, health technology assessment and Australia's place in the global context

Report cover image.png
Image.png

Submission to the PBAC on the Base Case Discount Rate

Report commissioned by Medicines Australia and prepared with Biointelect.

January 2022

Medicines Australia's submission to Australia's Pharmaceutical Benefits Advisory Committee on the rationale for reducing the base case discount rate used by the PBAC to evaluate medicines and vaccines for public subsidy.

Image discount rate report.png

Getting Australia to the front of the queue

Report prepared for Johnson & Johnson

December 2021

Report prepared on trends in global health, health policy, health technology assessment and Australia's place in the global context